Clinical trials for Cancer in United States

Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment

Study ID: NCT06532773

Sponsor

Duke University

The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists

Study ID: NCT03049462

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Exploration of Personalized Biomarkers During Neoadjuvant Radiation Therapy for Spinal and Sacral Chordoma

Study ID: NCT06463262

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors

Study ID: NCT04258462

Sponsor

Z is very Wang, MD

Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?

Study ID: NCT04723862

Sponsor

University of Virginia

Phase II Study of Pirtobrutinib, Rituximab (PR) in Previously Untreated Low and Intermediate Risk MCL (Mantle Cell Lymphoma) Patients

Study ID: NCT06263491

Sponsor

M.D. Anderson Cancer Center

Biomarkers to Predict Cancer Therapy-related Cardiotoxicity

Study ID: NCT06353191

Sponsor

Mayo Clinic

Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...

Study ID: NCT05470491

Sponsor

National Cancer Institute (NCI)

Window of Opportunity Study of DSP-0390 in Gliomas

Study ID: NCT06636162

Sponsor

Washington University School of Medicine

Behavioral Health Evaluation and Intervention Program for Patients Undergoing Craniotomy

Study ID: NCT05789862

Sponsor

University of California, San Francisco